Structure via PubChem · Public domain (PubChem)
lemborexant
Sign in to saveIn the Vinony graph
Vinony's link graph records 306 inbound references to lemborexant, and connects out to biological half-life, pharmacokinetics and 4-hydroxybutyric acid.
Vinony files it under 3-Fluorophenyl compounds, Carboxamides and Cyclopropanes.
Vinony links it to 15 Wikipedia language editions.
Chemical data
- Formula
- C22H20F2N4O2
- Molecular weight
- 410.4 g/mol
- IUPAC name
- cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide
- SMILES
- CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C
- InChIKey
- MUGXRYIUWFITCP-PGRDOPGGSA-N
- XLogP
- 3.2
- Polar surface area
- 77 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2020
- Admin. routes
- oral
- Indications
- insomnia, liver disease, obstructive sleep apnea, kidney disease
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 410.155
Show 4 more facts
- isomeric SMILES
- CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C
- canonical SMILES
- CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C
- chemical formula
- C₂₂H₂₀F₂N₄O₂
- Commons category
- Lemborexant
via Wikidata · CC0
~6 min read
Encyclopedic overview
12 sectionsContents
- Medical uses
- Available forms
- Side effects
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Society and culture
- Names
- Availability
- Research
- References
thumb|Blister pack of the orexin receptor antagonist "Lemborexant" available in Japan
Lemborexant, sold under the brand name Dayvigo, is an orexin antagonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset and/or maintenance in adults. The medication is taken by mouth.
Excerpted from Wikipedia’s “lemborexant” article, available under the CC BY-SA 4.0 licence.